Treatment
Treatment A clinical trials
We’re tracking 8,312 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT07024667Recruiting
Laser treatment study for vaginal atrophy symptoms
This trial tests a carbon dioxide laser (FemiLift) to see if it can help women with vaginal dryness, burning, itching, or pain during sex caused by menopause. It aims to improve symptoms without hormones.
HaderaAges 45–75 - NCT07025434Recruiting
Hip Bump Manipulation vs Sham in Healthy Adults
This study tests a hip adjustment technique (called hip bump manipulation) to see how it affects joint movement and muscles in healthy adults. If you join, you will receive either the real manipulation or a fake (sham) treatment, so researchers can compare the two.
Orangeburg, New YorkAges 18–45 - NCT07023952Recruiting
Phenol plus laser for pilonidal sinus healing study
This trial tests if adding phenol treatment to laser therapy helps the wound heal faster and better after treating pilonidal sinus (a small tunnel in the skin near the tailbone). It is for people who have this condition for the first time and have only a few sinus openings.
Istanbul, OtherAges 18 years+ - NCT07033416Recruiting
Training to reduce cocaine cravings
This trial tests a computer training program that helps people with cocaine use disorder change their automatic reactions to drug cues. The goal is to see if this training can reduce cravings and improve treatment outcomes.
Milan, MilanoAges 18 years+ - NCT07032363Recruiting
Depression and HIV treatment support study
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
Cape TownAges 18 years+ - NCT07027930Recruiting
EMDR group therapy for traffic accident trauma
This study tests a type of therapy called EMDR (which uses eye movements to help process trauma) in a group setting for people who are still struggling with stress symptoms from a past road traffic accident. It aims to see if this approach is helpful and practical.
Lahore, Punjab ProvinceAges 18–45 - NCT07033819RecruitingPhase 2
Fuzuloparib and apatinib before surgery for ovarian cancer
This trial tests a combination of two oral drugs—fuzuloparib (a PARP inhibitor) and apatinib (which blocks blood vessel growth to tumors)—given before surgery for advanced ovarian cancer that cannot be removed right away. It is for people whose tumors have a specific genetic marker (HRD positive) and who have not had prior cancer treatment.
Beijing, Beijing MunicipalityAges 18–70 - NCT05838066RecruitingPhase 3
KN026 plus HB1801 for HER2-positive advanced breast cancer
This Phase 3 study tests whether taking KN026 with HB1801 as first treatment works better and is safe for people with HER2-positive breast cancer that has come back or spread. It may help by improving tumor response and delaying progression compared with the study’s treatment plan.
Beijing, chaoyangAges 18 years+ - NCT07015944Recruiting
Moving on after breast cancer: a depression trial for survivors in Pakistan
This study tests a program called "Moving on After Breast Cancer" for women in Pakistan who have finished breast cancer treatment and now have depression. The goal is to see if this program helps them feel better emotionally.
Karachi, SindhAges 18 years+ - NCT07015073Recruiting
Comparing laser combinations for port-wine stains
This trial tests whether using two different lasers one after the other works better than a single laser for treating port-wine stains (a type of birthmark). The goal is to see if the combination treatment can improve appearance with fewer sessions.
Madrid, SpainAges 18 years+ - NCT07021534RecruitingPhase 1
CAR-NK and CAR-T cells for cancer with liver spread
This trial tests a new treatment that uses special immune cells (CAR-NK and CAR-T cells) given directly into the liver artery, then through a vein, to fight advanced solid tumors that have spread to the liver. It is for people who have already tried standard treatments and need new options.
Hangzhou, ZhejiangAges 18–75 - NCT07010419RecruitingPhase 3
Firmonertinib vs placebo for early-stage lung cancer with rare EGFR mutations
This trial tests if Firmonertinib, a targeted pill, can prevent lung cancer from returning after surgery in people with non-small cell lung cancer that has certain uncommon EGFR gene changes. If you have had complete tumor removal and have one of these specific mutations, this study may help you stay cancer-free longer.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07012668Recruiting
Treatments for heart-brain conditions and post-surgery stroke
This trial is studying different treatments for people who have conditions that affect both the heart and brain, or who have had a stroke or other brain blood vessel problem after heart surgery. The goal is to find out which treatments work best and see what factors affect the results.
BeijingAges 18 years+ - NCT07010679Enrolling by invitation
How patients decide about sinus surgery
This study looks at how people with long-term sinus problems decide whether to have sinus surgery. Researchers want to understand what matters most to patients when choosing treatment.
Arcadia, CaliforniaAges 18 years+ - NCT06998862RecruitingPhase 3
Colchicine for people with chronic kidney disease
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
Madrid, MadridAges 18–99 - NCT06997003Recruiting
Study of a new laser for vision correction
This study tests a new laser (called TENEO 317 Model 2) for vision correction. If you're already scheduled for LASIK to fix nearsightedness or farsightedness (with or without astigmatism), you may be eligible. The study checks if this new laser is safe and works well.
Zlín, Czech RepublicAges 18 years+ - NCT06999005Recruiting
Dental cavity treatment study for children ages 6-12
This study tests two gentle cavity treatments for children's permanent molars. It aims to find which method works best over two years.
Santos, São PauloAges 6–12 - NCT06984822Recruiting
Comparing eye injections for diabetic macular edema
This study compares two different eye injection treatments for diabetic macular edema (DME)—a condition where fluid builds up in the center of the retina, blurring vision. Researchers want to see how certain measures in the blood and in eye scans relate to how well each treatment works.
MölndalAges 18 years+ - NCT06992362RecruitingPhase 2
Pre- and post-surgery treatment for HER2+ hepatoid stomach cancer
This trial tests a treatment plan given before and after surgery for a rare type of stomach cancer called hepatoid adenocarcinoma. It's for people whose tumors have a specific HER2 protein marker and are at an early enough stage that surgery is still possible.
BeijingAges 18–75 - NCT06981325RecruitingPhase 2
Cemiplimab for advanced basal cell carcinoma
This trial tests cemiplimab, an immunotherapy drug, as a first treatment for advanced basal cell carcinoma that cannot be removed with surgery or radiation. The goal is to see if it can shrink or control the cancer.
ErfurtAges 18 years+ - NCT06966206RecruitingPhase 3
Study of Multiprofen-CC for hand arthritis pain
This trial tests a topical medication called Multiprofen-CC to reduce pain and improve hand function in people with hand arthritis. If you have hand osteoarthritis and it affects your daily life, you may be able to join.
Hamilton, OntarioAges 18 years+ - NCT06969235Recruiting
Family weight loss program for teens
This study tests a family-based weight loss program for teens ages 13-17 who have overweight or obesity. It looks at how thinking skills (like planning and focus) affect the program's success.
Columbia, MissouriAges 13–17 - NCT06955429Recruiting
Testing Biodentine XP for tooth fillings and root treatments
This study tests how well Biodentine XP works over time for fixing cavities or treating tooth roots in children and adults. It aims to see if this material is safe and lasts long in both baby teeth and permanent teeth.
KraainemAges 2 years+ - NCT06959511RecruitingPhase 2
Zanzalintinib for advanced thyroid cancer before surgery
This trial tests a drug called zanzalintinib for people with advanced thyroid cancer that has spread nearby. The goal is to see if taking this pill before surgery can shrink the tumor and make it easier to remove.
Ann Arbor, MichiganAges 18 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.